Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Synosia Therapeutics
company
About
Synosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.
- 1 - 10
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $30M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Synosia Therapeutics develops and intends to commercialise products for unmet medical needs in psychiatry and neurology. The privately-owned company has in its pipeline six clinical-stage compounds acquired through partnerships with Novartis, Roche and Syngenta. Two of the compounds are marketed drugs being tested in new indications to extend their reach into neurological and psychiatric diseases with high unmet medical need, including anxiety and Parkinson's disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$91.50M
Synosia Therapeutics has raised a total of
$91.50M
in funding over 2 rounds. Their latest funding was raised on
Oct 12, 2010 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 12, 2010 | Series C | $30M | 2 |
UCB
|
— | Detail |
| Jan 1, 2009 | Series B | $29M | 1 | — | — | Detail |
| Jan 5, 2007 | Series Unknown | $32.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Synosia Therapeutics is funded by 2 investors.
UCB
and Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
UCB
|
Yes | Series C |
Versant Ventures
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
